A
Adipo Therapeutics
Innovative nanoparticle therapy transforming white fat to brown, enhancing energy expenditure and insulin sensitivity
About Adipo Therapeutics
Adipo Therapeutics, based in West Lafayette, Indiana, is a pioneering biotechnology company focused on developing advanced treatments for obesity and type 2 diabetes. The company leverages a unique technology platform that utilizes polymer-based, Notch-inhibiting nanoparticles. These nanoparticles are injected directly into adipose (fat) tissue to induce the transformation of white fat cells into beige or brown fat cells, a process known as adipocyte browning. This transformation aims to increase energy expenditure and improve insulin sensitivity, offering a novel approach to managing metabolic disorders.
Read full description
Adipo Therapeutics primarily serves patients suffering from obesity and type 2 diabetes, conditions that are prevalent in both developed and developing markets. The company operates within the biotechnology and pharmaceutical sectors, targeting healthcare providers, endocrinologists, and metabolic disorder specialists as its key clients.
The business model of Adipo Therapeutics revolves around the development and commercialization of its innovative nanoparticle therapy. Revenue is generated through the sale of its therapeutic products, potential licensing agreements, and partnerships with larger pharmaceutical companies. The company may also explore opportunities for grants and funding from healthcare and research institutions to support its ongoing research and development efforts.
At a glance
- Founded
- 2017
- Headquarters
- Indianapolis, United States
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning Adipo Therapeutics.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
- RARacine Medical Angels
Purdue Innovates Ventures
VisionTech Partners
Elevate Ventures
IU Ventures
Purdue Research Foundation
Series B and later1 investor entered at this stage
Indianabiosciences
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Adipo Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Adipo Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.